ATI RN
CNS Drugs Pharmacology PDF Questions
Question 1 of 5
The major reason why carbidopa is of value in parkinsonism is that the compound
Correct Answer: C
Rationale: Carbidopa is a valuable drug in the treatment of Parkinsonism because it inhibits the enzyme aromatic L-amino acid decarboxylase (AADC). This enzyme is responsible for converting levodopa to dopamine outside the central nervous system (CNS), leading to peripheral side effects and reduced levodopa availability in the brain. By inhibiting AADC, carbidopa allows more levodopa to reach the brain and be converted to dopamine centrally, improving motor symptoms of Parkinsonism. Option A is incorrect because carbidopa itself does not need to cross the blood-brain barrier to exert its effects. Option B is incorrect as carbidopa does not inhibit monoamine oxidase type A. Option D is also incorrect as carbidopa is not converted to carbidopamine. Understanding the mechanism of action of carbidopa in conjunction with levodopa is crucial for healthcare professionals managing Parkinson's disease. This combination therapy is commonly used to enhance levodopa's efficacy and reduce peripheral side effects. By knowing the role of carbidopa in inhibiting AADC, healthcare providers can optimize treatment regimens for patients with Parkinsonism, leading to better symptom control and improved quality of life.
Question 2 of 5
Which one of the following drugs is most likely to increase plasma levels of alprazolam, theophylline, and warfarin?
Correct Answer: B
Rationale: In this question, the correct answer is B) Fluvoxamine. Fluvoxamine is a potent inhibitor of the cytochrome P450 enzyme CYP1A2, which is responsible for the metabolism of alprazolam, theophylline, and warfarin. By inhibiting this enzyme, fluvoxamine can increase the plasma levels of these drugs, leading to potential drug interactions and toxicity. Desipramine (option A) and Imipramine (option C) are tricyclic antidepressants that do not have a significant effect on the metabolism of alprazolam, theophylline, or warfarin, making them less likely to increase their plasma levels. Nefazodone (option D) is a serotonin modulator and stimulator that does not have a significant effect on CYP1A2 metabolism, so it is also less likely to increase the plasma levels of alprazolam, theophylline, or warfarin. Understanding drug interactions and how different medications can affect the metabolism of others is crucial in pharmacology to prevent adverse effects and ensure the safe and effective use of medications in clinical practice. Fluvoxamine's potent inhibition of CYP1A2 underscores the importance of considering potential drug interactions when prescribing medications to patients taking alprazolam, theophylline, or warfarin.
Question 3 of 5
A patient suffering from a depressive disorder is being treated with imipramine. If he uses diphenhydramine for allergic rhinitis, a drug interaction is likely to occur because
Correct Answer: D
Rationale: The correct answer is D) Both drugs block muscarinic receptors. Imipramine is a tricyclic antidepressant that blocks the reuptake of norepinephrine and serotonin. Diphenhydramine is an antihistamine that also has anticholinergic effects by blocking muscarinic receptors. When used together, the combination of imipramine and diphenhydramine can lead to additive anticholinergic effects due to their combined action on muscarinic receptors. Option A is incorrect because diphenhydramine does not inhibit imipramine metabolism; instead, they may have additive effects due to their overlapping pharmacological actions. Option B is incorrect because while both drugs affect neurotransmitters, they do so through different mechanisms - imipramine primarily affects norepinephrine and serotonin reuptake, while diphenhydramine primarily blocks histamine receptors. Option C is incorrect as imipramine does not inhibit the metabolism of diphenhydramine. This question highlights the importance of understanding drug interactions, especially when combining medications with overlapping or opposing mechanisms of action. Healthcare providers need to be aware of potential interactions to prevent adverse effects and optimize patient care.
Question 4 of 5
This agent is currently a first-choice drug in the management of absence seizures as well as partial, primary generalized, and tonic-clonic seizures.
Correct Answer: A
Rationale: The correct answer is A) Valproic acid. Valproic acid is a broad-spectrum antiepileptic drug that is considered a first-line treatment for various types of seizures, including absence seizures, partial seizures, primary generalized seizures, and tonic-clonic seizures. Valproic acid works by increasing the levels of the inhibitory neurotransmitter GABA in the brain, which helps to reduce excessive neuronal activity and prevent seizures. Its broad efficacy and relatively favorable side effect profile make it a preferred choice for managing different seizure types. Option B) Clonazepam is a benzodiazepine commonly used for absence seizures, but it is not typically considered a first-line agent for other seizure types mentioned in the question. Option C) Ethosuximide is primarily indicated for the treatment of absence seizures and is not as effective for other seizure types mentioned in the question. Option D) Phenytoin is more commonly used for partial and tonic-clonic seizures but is not typically a first-line choice for absence seizures. Educationally, understanding the mechanism of action and specific indications of antiepileptic drugs is crucial for healthcare practitioners to make informed decisions when managing patients with seizures. Knowing the first-line agents for different seizure types helps in optimizing treatment outcomes and minimizing potential side effects.
Question 5 of 5
Which of the following is a common effect of muscarinic stimulant drugs?
Correct Answer: D
Rationale: In pharmacology, muscarinic stimulant drugs target the muscarinic acetylcholine receptors in the parasympathetic nervous system. The correct answer is D) Miosis, which refers to constriction of the pupil. Activation of muscarinic receptors by stimulant drugs leads to miosis as one of the common effects. This occurs due to the stimulation of the iris sphincter muscle. Now let's analyze why the other options are incorrect: A) Decreased peristalsis: Muscarinic stimulant drugs actually increase peristalsis in the gastrointestinal tract by enhancing smooth muscle contractions. B) Decreased secretion by salivary glands: Muscarinic stimulant drugs increase salivary gland secretion, not decrease it. C) Hypertension: Muscarinic stimulant drugs are more likely to cause hypotension rather than hypertension due to vasodilation effects. From an educational perspective, understanding the effects of muscarinic stimulant drugs is crucial in pharmacology. Knowing how these drugs affect various systems in the body helps healthcare professionals in clinical decision-making, patient care, and management of drug-related adverse effects. It is essential to differentiate between the effects of muscarinic stimulant drugs to ensure safe and effective medication administration.